Knockdown of the SREBP1c gene can significantly inhibit the proliferation, invasion, and migration of gastric cancer cells, thus providing novel evidence supporting SREBP-1c as a potential therapeutic biomarker target for gastric cancer. The gene discussed is SREBF1; the disease is gastric cancer.